FilingReader Intelligence
Jumpcan Pharmaceutical suspended amid tender offer outcome
July 17, 2025 at 05:10 PM UTC•By FilingReader AI
Hubei Jumpcan Pharmaceutical shares will be suspended for one day to finalize results of a tender offer for 350,841,357 shares, representing 38.06% of total share capital.
The offer price was 24.85 yuan per share. Trading resumes July 21 following the outcome announcement.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SSE:600566•Shanghai Stock Exchange
News Alerts
Get instant email alerts when Hubei Jumpcan Pharmaceutical publishes news
Free account required • Unsubscribe anytime